Efficacy of L-DOPA therapy in Parkinson's disease
L-3,4-dihydroxyphenylalanine (L-DOPA) isa classical example of an amino acid that isan immediate precursor to dopamine andhas been developed as an effective therapeuticagent for a neurodegenerative disease.Dopamine deficiency is known to be acore pathogenic event in Parkinson's disease(PD). It is the main neurotransmitter responsiblefor modulation of motor behaviour.Peripherally given, L-DOPA is t
